ALGS
Price
$8.50
Change
-$0.19 (-2.19%)
Updated
Jul 15 closing price
Capitalization
51.98M
CRNX
Price
$32.58
Change
+$0.75 (+2.36%)
Updated
Jul 16, 11:19 AM (EDT)
Capitalization
2.98B
22 days until earnings call
Interact to see
Advertisement

ALGS vs CRNX

Header iconALGS vs CRNX Comparison
Open Charts ALGS vs CRNXBanner chart's image
Aligos Therapeutics
Price$8.50
Change-$0.19 (-2.19%)
Volume$50.71K
Capitalization51.98M
Crinetics Pharmaceuticals
Price$32.58
Change+$0.75 (+2.36%)
Volume$865
Capitalization2.98B
ALGS vs CRNX Comparison Chart in %
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. CRNX commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and CRNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (ALGS: $8.50 vs. CRNX: $31.83)
Brand notoriety: ALGS and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 38% vs. CRNX: 152%
Market capitalization -- ALGS: $51.98M vs. CRNX: $2.98B
ALGS [@Biotechnology] is valued at $51.98M. CRNX’s [@Biotechnology] market capitalization is $2.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • ALGS’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, ALGS is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 5 TA indicator(s) are bullish while CRNX’s TA Score has 5 bullish TA indicator(s).

  • ALGS’s TA Score: 5 bullish, 4 bearish.
  • CRNX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than CRNX.

Price Growth

ALGS (@Biotechnology) experienced а +3.16% price change this week, while CRNX (@Biotechnology) price change was +8.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.66%. For the same industry, the average monthly price growth was +10.10%, and the average quarterly price growth was +38.79%.

Reported Earning Dates

ALGS is expected to report earnings on May 06, 2025.

CRNX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.98B) has a higher market cap than ALGS($52M). CRNX YTD gains are higher at: -37.747 vs. ALGS (-78.665). ALGS has higher annual earnings (EBITDA): -83.89M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. ALGS (138M). ALGS has less debt than CRNX: ALGS (7.87M) vs CRNX (50.8M). ALGS has higher revenues than CRNX: ALGS (3.27M) vs CRNX (760K).
ALGSCRNXALGS / CRNX
Capitalization52M2.98B2%
EBITDA-83.89M-373.49M22%
Gain YTD-78.665-37.747208%
P/E RatioN/AN/A-
Revenue3.27M760K430%
Total Cash138M1.27B11%
Total Debt7.87M50.8M16%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALGSCRNX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 6 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WBEIX14.080.23
+1.66%
William Blair Emerging Mkts Growth I
DEMGX12.780.03
+0.24%
DFA Emerging Markets Trgt Val Instl
STFBX91.30N/A
N/A
State Farm Balanced
GFSIX18.78N/A
N/A
Gabelli Global Financial Services I
MRSHX25.31-0.18
-0.71%
MFS Research International R3

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with XNCR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-2.19%
XNCR - ALGS
41%
Loosely correlated
-4.63%
STRO - ALGS
39%
Loosely correlated
-1.74%
RLAY - ALGS
38%
Loosely correlated
-1.69%
CRNX - ALGS
35%
Loosely correlated
-3.60%
ARWR - ALGS
34%
Loosely correlated
-5.27%
More